NutriBand price to book ratio NTRB
Market value divided by the book value of the company's net assets, since 2021.
- Today, Oct 23, 2026
- 13.1×
- 5-year median
- 4.3×
- Against its 5-year history
- 92nd
- percentile: 0 is its lowest day, 100 its highest
- 5-year range
- 1.7× to 21.7×
- Peer median
- 2.5×
NutriBand's price to book ratio is 13.1× as of Oct 23, 2026.
That is above its 5-year median of 4.3×, higher than on 92% of days in the last 5 years.
Over that time it ranged from 1.7× in Dec 2021 to 21.7× in Jul 2025.
The median for 9 medical instruments and supplies stocks of a similar size is 2.5×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 13.1× | 5.8× | 18.5× |
| 2025 | 7.7× | 4.1× | 21.7× |
| 2024 | 3.8× | 3.3× | 8.7× |
| 2023 | 3.2× | 2.3× | 4.5× |
| 2022 | 2.9× | 1.7× | 3.5× |
| 2021 | 4.7× | 1.7× | 5.9× |
Against its peers
Companies in Medical - Instruments & Supplies nearest NutriBand's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| NTRBNutriBand | 13.1× |
| APTAlpha Pro Tech | 0.9× |
| KEQUKewaunee Scientific | 1.3× |
| NEPHNephros | 3.2× |
| PDEXPro DEX | 4.2× |
| UTMDUtah Medical Products | 1.9× |
| INFUInfuSystem | 4.7× |
| EMBCEmbecta | n/m |
| TCMDTactile Systems Technology | 2.4× |
| MDXGMimedx | 2.6× |
| Peer median | 2.5× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on NutriBand
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.